Antineoplaston Therapy in Treating Patients With Metastatic or Unresectable Colon Cancer
Status:
Terminated
Trial end date:
2003-05-11
Target enrollment:
Participant gender:
Summary
Current therapies for metastatic or unresectable Colon Cancer provide very limited benefit to
the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove
beneficial in the treatment of metastatic or unresectable Colon Cancer.
PURPOSE: This study is being performed to determine the effects (good and bad) that
Antineoplaston therapy has on patients with metastatic or unresectable Colon Cancer